Copyright
©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Stem Cells. Apr 26, 2017; 9(4): 68-76
Published online Apr 26, 2017. doi: 10.4252/wjsc.v9.i4.68
Published online Apr 26, 2017. doi: 10.4252/wjsc.v9.i4.68
Fifteen years of bone marrow mononuclear cell therapy in acute myocardial infarction
Miruna Mihaela Micheu, Maria Dorobantu, Department of Cardiology, Clinical Emergency Hospital of Bucharest, 014461 Bucharest, Romania
Author contributions: Both authors equally contributed to the conception of the paper, the literature review and analysis, drafting and to critically revising and editing the manuscript.
Conflict-of-interest statement: Authors declare no conflict of interests for this article. No financial support.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Miruna Mihaela Micheu, MD, PhD, Department of Cardiology, Clinical Emergency Hospital of Bucharest, Floreasca Street 8, 014461 Bucharest, Romania. mirunamicheu@yahoo.com
Telephone: +40-72-2451755
Received: January 6, 2017
Peer-review started: January 10, 2017
First decision: February 17, 2017
Revised: March 16, 2017
Accepted: April 18, 2017
Article in press: April 19, 2017
Published online: April 26, 2017
Processing time: 107 Days and 11.2 Hours
Peer-review started: January 10, 2017
First decision: February 17, 2017
Revised: March 16, 2017
Accepted: April 18, 2017
Article in press: April 19, 2017
Published online: April 26, 2017
Processing time: 107 Days and 11.2 Hours
Core Tip
Core tip: Since the first successful bone marrow stem cells transplantation performed 15 years ago in a patient with acute myocardial infarction, we have witnessed a mounting body of data as regards this cutting-edge therapy. During the reporting period, conflicting results have been stated, scientific papers have been under investigation, strategies to enhance the stem cells regenerative potential have been applied and/or suggested, position papers and recommendations have been published. This review will analytically discuss each of the above topics, summarizing the current state of knowledge in the field.